People: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

87.45CHF
10:55am EDT
Price Change (% chg)

CHF0.55 (+0.63%)
Prev Close
CHF86.90
Open
CHF87.10
Day's High
CHF87.70
Day's Low
CHF86.10
Volume
3,710,607
Avg. Vol
4,997,300
52-wk High
CHF90.60
52-wk Low
CHF67.45

Search Stocks

Azar, Dimitri 

Brief Biography

Dr. Dimitri Azar, M.D., has served as Member of the Board of Directors of Novartis AG since February 2012. He qualifies as an independent Non-Executive Director. He is Dean of the College of Medicine and professor of ophthalmology, bioengineering and pharmacology at the University of Illinois at Chicago in the United States, where he formerly was Head of the Department of Ophthalmology and Visual Sciences. He sits on the Board of Trustees of the Chicago Ophthalmological Society and the Association of Research in Vision and Ophthalmology. Dr. Azar is Member of the American Ophthalmological Society and holds committee positions with the American Academy of Ophthalmology. Dr. Azar began his career at the American University Medical Center, Beirut, Lebanon, and completed his fellowship and residency training at the Massachusetts Eye and Ear Infirmary at Harvard Medical School in the United States. Dr. Azar practiced at the Wilmer Ophthalmologic Institute at The Johns Hopkins Hospital School of Medicine, then returned to the Massachusetts Eye and Ear Infirmary as director of the cornea and external disease. He became professor of ophthalmology with tenure at Harvard Medical School in 2003. Dr. Azar holds an Executive Master of Business Administration from the University of Chicago, Booth School of Business.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
140,000 -- 210,025 350,025

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joerg Reinhardt

1,366,320

Joseph Jimenez

13,228,200

Ulrich Lehner

853,107

Harry Kirsch

--

Peter Kornicker

--

Felix Ehrat

3,584,790
As Of 30 Dec 2012
Search Stocks